Tom Smets

Tom Smets is currently working as a Board Observer at ABSCINT and an Investment Analyst at Qbic Fund | Venture Capital. Tom previously held positions in Quality & Compliance Engineering and as a Team Lead at Ordina, where Tom worked on guiding companies towards compliance. Tom has experience as a Validation Consultant at The Janssen Pharmaceutical Companies of Johnson & Johnson and EMVO, and as a Project Engineer at Pfizer. Tom also served as Treasurer and Board Member at Vlaamse Levenstechnische kring. Tom has a postgraduate degree in Innovation and Entrepreneurship, a Master's degree in Bioscience Engineering, and a Bachelor's degree in Bioscience Engineering.